NCT06376240View on ClinicalTrials.gov

The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 21, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 DiabetesMicrovascular FunctionRetinopathy, DiabeticNephropathy, DiabeticNeuropathy, Diabetic
Interventions
DIETARY_SUPPLEMENT

Pyridoxamine 300mg per day

oral supplement

OTHER

Placebo 300mg placebo per day

oral supplement

Trial Locations (1)

6229 HX

RECRUITING

Academic Hospital Maastricht, Maastricht

Sponsors

Collaborators (1)

Diabetes Fonds
All Listed Sponsors
collaborator

Diabetes Fonds

OTHER

lead

Maastricht University Medical Center

OTHER

NCT06376240 - The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes | Biotech Hunter | Biotech Hunter